Chronic Pain Syndrome Clinical Trial
Official title:
Impact of Psychology on Life Quality in Chronic and Cancer Pain Patients
This study is to compare the effect of pain management program. We compare life quality, pain scores, sleep, anxiety and depression scores, and self report measures before and after mindfulness based pain management workshops.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | March 30, 2021 |
Est. primary completion date | March 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion Criteria: - Pain condition for over six months, with diagnosis by pain physician to be of chronic pain or cancer pain. Exclusion Criteria: - Patients unable to communicate in Mandarin. |
Country | Name | City | State |
---|---|---|---|
Taiwan | Taipei Veterans General Hospital | Taipei City |
Lead Sponsor | Collaborator |
---|---|
Taipei Veterans General Hospital, Taiwan |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Baseline Brief Pain inventory | Assesses the severity of pain and its impact on functioning | Baseline | |
Primary | Four week Brief Pain inventory | Assesses the severity of pain and its impact on functioning | Participants answer questionnaire at 4 weeks into pain management program | |
Primary | Eight weeks Brief Pain inventory | Assesses the severity of pain and its impact on functioning | Participants answer questionnaire at 8 weeks into pain management program | |
Primary | One year Brief Pain inventory | Assesses the severity of pain and its impact on functioning | Participants answer questionnaire at one year after completion of pain management program | |
Secondary | Baseline Visual analog scale | Pain scale at numbers 0 to 10 | Baseline | |
Secondary | Four week Visual analog scale | Pain scale at numbers 0 to 10 | Participants answer questionnaire at 4 weeks into pain management program | |
Secondary | Eight week Visual analog scale | Pain scale at numbers 0 to 10 | Participants answer questionnaire at 8 weeks into pain management program | |
Secondary | One year Visual analog scale | Pain scale at numbers 0 to 10 | Participants answer questionnaire at one year after completion of pain management program | |
Secondary | Baseline Pain self-efficacy questionnaire | Assess the confidence people with ongoing pain have in performing activities while in pain. | Baseline | |
Secondary | Four week Pain self-efficacy questionnaire | Assess the confidence people with ongoing pain have in performing activities while in pain. | Participants answer questionnaire at 4 weeks into pain management program | |
Secondary | Eight week Pain self-efficacy questionnaire | Assess the confidence people with ongoing pain have in performing activities while in pain. | Participants answer questionnaire at 8 weeks into pain management program | |
Secondary | One year Pain self-efficacy questionnaire | Assess the confidence people with ongoing pain have in performing activities while in pain. | Participants answer questionnaire at one year after completion of pain management program | |
Secondary | Baseline Pain catastrophizing scale | self-report measurement tool that provided a valid index of catastrophizing in clinical and non-clinical populations | Baseline | |
Secondary | Four week Pain catastrophizing scale | self-report measurement tool that provided a valid index of catastrophizing in clinical and non-clinical populations | Participants answer questionnaire at 4 weeks into pain management program | |
Secondary | Eight week Pain catastrophizing scale | self-report measurement tool that provided a valid index of catastrophizing in clinical and non-clinical populations | Participants answer questionnaire at eight weeks into pain management program | |
Secondary | One year Pain catastrophizing scale | self-report measurement tool that provided a valid index of catastrophizing in clinical and non-clinical populations | Participants answer questionnaire at one year after completion of pain management program | |
Secondary | Baseline Depression, anxiety, and positive outlook scale | Assess mood in pain patients | Baseline | |
Secondary | Four week Depression, anxiety, and positive outlook scale | Assess mood in pain patients | Participants answer questionnaire at 4 weeks into pain management program | |
Secondary | Eight week Depression, anxiety, and positive outlook scale | Assess mood in pain patients | Participants answer questionnaire at 8 weeks into pain management program | |
Secondary | One year Depression, anxiety, and positive outlook scale | Assess mood in pain patients | Participants answer questionnaire at one year after completion of pain management program | |
Secondary | Baseline Chronic Pain Acceptance Questionnaire | Assessment of acceptance of pain. | Baseline | |
Secondary | Four week Chronic Pain Acceptance Questionnaire | Assessment of acceptance of pain. | Participants answer questionnaire at 4 weeks into pain management program | |
Secondary | Eight week Chronic Pain Acceptance Questionnaire | Assessment of acceptance of pain. | Participants answer questionnaire at 8 weeks into pain management program | |
Secondary | One year Chronic Pain Acceptance Questionnaire | Assessment of acceptance of pain. | Participants answer questionnaire at one year after completion of pain management program | |
Secondary | Baseline Five Facet Mindfulness Questionnaire | Assessment on the five aspects of mindfulness | Baseline | |
Secondary | Four week Five Facet Mindfulness Questionnaire | Assessment on the five aspects of mindfulness | Participants answer questionnaire at 4 weeks into pain management program | |
Secondary | Eight week Five Facet Mindfulness Questionnaire | Assessment on the five aspects of mindfulness | Participants answer questionnaire at 8 weeks into pain management program | |
Secondary | One year Five Facet Mindfulness Questionnaire | Assessment on the five aspects of mindfulness | Participants answer questionnaire at one year after completion of pain management program | |
Secondary | Baseline Pittsburgh Sleep Quality Index | Assesses sleep quality | Baseline | |
Secondary | Four week Pittsburgh Sleep Quality Index | Assesses sleep quality | Participants answer questionnaire at four weeks into pain management program | |
Secondary | Eight week Pittsburgh Sleep Quality Index | Assesses sleep quality | Participants answer questionnaire at 8 weeks into pain management program | |
Secondary | One year Pittsburgh Sleep Quality Index | Assesses sleep quality | Participants answer questionnaire at one year after completion of pain management program |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01417923 -
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
|
Phase 4 | |
Completed |
NCT03472521 -
Prevention of Persistent Opioid Use in Mothers
|
Phase 4 | |
Not yet recruiting |
NCT03249025 -
Lidocaine-Ketamine for Management of Chronic Pain
|
N/A | |
Enrolling by invitation |
NCT06359561 -
Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients With Cervical Lead Placement
|
||
Recruiting |
NCT05877274 -
Sodium Channel Mutations in Patient With the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
|
||
Completed |
NCT03317782 -
NoL Index Variations Before and After a Stellate Ganglion Block
|
||
Completed |
NCT04199858 -
Electrophysiological Correlates of Nocebo Effects on Pain
|
N/A | |
Recruiting |
NCT05491499 -
Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes
|
||
Active, not recruiting |
NCT05090683 -
Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain.
|
N/A | |
Completed |
NCT04197154 -
Pain-related Fear as a Facilitator of Nocebo Hyperalgesia
|
N/A | |
Completed |
NCT04209764 -
Prevalence of Pain in the Departments of Surgery and Oncoematology of a Children's Hospital
|
||
Recruiting |
NCT06071975 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
|
Phase 3 | |
Recruiting |
NCT06072560 -
Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
|
Phase 3 | |
Recruiting |
NCT06071936 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06071949 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Recruiting |
NCT06071962 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
|
Phase 3 | |
Recruiting |
NCT06072001 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Recruiting |
NCT06072573 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
|
Phase 3 | |
Recruiting |
NCT06071988 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Completed |
NCT03460717 -
Thermal Micro-cautery for Painful Knee Osteoarthritis
|
N/A |